Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates.

Amino Acid Sequence Animals Biological Evolution Heterozygote Hominidae Humans Killer Cells, Natural / immunology Models, Molecular Phylogeography Primates / genetics Protein Binding Protein Conformation Protein Interaction Domains and Motifs Receptors, KIR / chemistry Selection, Genetic Signal Transduction Structure-Activity Relationship
HLA class I KIR KIR3DL3 NK cells comparative evolution infectious disease reproduction

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 10 12 2018
accepted: 07 01 2019
entrez: 13 2 2019
pubmed: 13 2 2019
medline: 21 12 2019
Statut: epublish

Résumé

Natural killer (NK) cell functions are modulated by polymorphic killer cell immunoglobulin-like receptors (KIR). Among 13 human

Identifiants

DOI: 10.3389/fimmu.2019.00024 PMID: 30745901 PMC: PMC6360152
pubmed: 30745901
doi: 10.3389/fimmu.2019.00024
pmc: PMC6360152
doi:

Substances chimiques

KIR3DL3 protein, human 0
Receptors, KIR 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI090905
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI017892
Pays : United States
Organisme : NINDS NIH HHS
ID : U19 NS095774
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Références

Immunogenetics. 2010 May;62(5):281-93
pubmed: 20195593
Genes Immun. 2016 Jan-Feb;17(1):66-74
pubmed: 26656451
Nat Immunol. 2008 May;9(5):495-502
pubmed: 18425106
Immunol Rev. 2001 Jun;181:223-33
pubmed: 11513144
Nat Immunol. 2001 May;2(5):452-60
pubmed: 11323700
Nature. 2011 Oct 23;479(7373):401-5
pubmed: 22020283
Nat Immunol. 2001 May;2(5):430-5
pubmed: 11323697
Nature. 2000 Jun 1;405(6786):537-43
pubmed: 10850706
J Immunol. 2003 Sep 1;171(5):2192-5
pubmed: 12928362
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15062-7
pubmed: 10611338
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
J Immunol. 2004 Jun 15;172(12):7385-92
pubmed: 15187115
EMBO J. 2004 Jan 28;23(2):255-9
pubmed: 14685277
Immunogenetics. 2006 Aug;58(8):614-27
pubmed: 16823588
Immunogenetics. 2006 Jan;57(12):904-16
pubmed: 16391939
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7
pubmed: 19837691
Immunol Rev. 2015 Sep;267(1):148-66
pubmed: 26284476
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31
pubmed: 25414341
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83
pubmed: 10781084
J Immunol. 2008 Nov 1;181(9):6301-8
pubmed: 18941221
J Immunol. 2010 Feb 1;184(3):1379-91
pubmed: 20026738
Hum Immunol. 2015 Sep;76(9):663-6
pubmed: 26416088
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31
pubmed: 9826699
PLoS One. 2015 Sep 30;10(9):e0139485
pubmed: 26421847
Science. 2012 Oct 12;338(6104):222-6
pubmed: 22936568
J Immunol. 2005 Apr 1;174(7):4135-43
pubmed: 15778373
BMC Genomics. 2013 Feb 08;14:89
pubmed: 23394822
Immunogenetics. 2011 Aug;63(8):543-7
pubmed: 21541786
J Exp Med. 2006 Mar 20;203(3):633-45
pubmed: 16533882
Mol Biol Evol. 2007 Jan;24(1):26-53
pubmed: 17047029
Genes Immun. 2017 Sep;18(3):127-134
pubmed: 28569259
Immunity. 2000 Jun;12(6):687-98
pubmed: 10894168
Sci Rep. 2017 Jul 21;7(1):6123
pubmed: 28733576
Immunol Rev. 2008 Aug;224:11-43
pubmed: 18759918
J Immunol. 2007 Jan 1;178(1):33-7
pubmed: 17182537
J Exp Med. 2002 Oct 7;196(7):911-21
pubmed: 12370253
Science. 2002 Apr 12;296(5566):261-2
pubmed: 11954565
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2662-7
pubmed: 24550293
J Immunol. 2005 Apr 1;174(7):3859-63
pubmed: 15778339
J Virol. 2013 May;87(9):5305-10
pubmed: 23449795
Tissue Antigens. 2015 Nov;86(5):362-7
pubmed: 26423800
PLoS Genet. 2013 Oct;9(10):e1003938
pubmed: 24204327
Immunol Rev. 2015 Sep;267(1):259-82
pubmed: 26284483
J Immunol. 2002 Jul 1;169(1):220-9
pubmed: 12077248
J Biol Chem. 2015 Apr 17;290(16):10460-71
pubmed: 25759384
Curr Opin Immunol. 2017 Feb;44:43-51
pubmed: 27984782
J Exp Med. 2004 Oct 18;200(8):957-65
pubmed: 15477349
PLoS One. 2012;7(11):e47491
pubmed: 23139747
Tissue Antigens. 2007 Dec;70(6):449-54
pubmed: 17900289
J Exp Med. 2001 Jan 1;193(1):135-46
pubmed: 11136827
Immunol Invest. 2008;37(5):565-82
pubmed: 18716938
J Exp Med. 2009 Oct 26;206(11):2557-72
pubmed: 19858347
J Immunol. 2012 Aug 1;189(3):1418-30
pubmed: 22772445
PLoS Genet. 2010 Nov 04;6(11):e1001192
pubmed: 21079681
Mol Biol Evol. 2013 May;30(5):1196-205
pubmed: 23420840
Immunity. 1996 Jan;4(1):77-85
pubmed: 8574854
Immunol Rev. 2001 Jun;181:66-78
pubmed: 11513153
Immunity. 1997 Dec;7(6):753-63
pubmed: 9430221
Am J Hum Genet. 2016 Aug 4;99(2):375-91
pubmed: 27486779
Immunogenetics. 2011 Sep;63(9):577-85
pubmed: 21614583
J Immunol. 2003 Aug 15;171(4):1768-74
pubmed: 12902476
J Immunol. 2010 Oct 1;185(7):4238-51
pubmed: 20805421
J Immunol. 2014 Jun 1;192(11):5069-73
pubmed: 24778445
Eur J Immunol. 1998 Dec;28(12):3959-67
pubmed: 9862332
J Exp Med. 2016 May 2;213(5):791-807
pubmed: 27045007
J Immunol. 2003 May 1;170(9):4539-47
pubmed: 12707331
Nature. 1988 Sep 8;335(6186):167-70
pubmed: 3412472
J Clin Invest. 2010 Nov;120(11):4102-10
pubmed: 20972337
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Eur J Immunol. 2011 Sep;41(9):2719-28
pubmed: 21710469
Immunology. 2011 Mar;132(3):315-25
pubmed: 21214544
Immunogenetics. 2011 Sep;63(9):549-59
pubmed: 21607693
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Exp Med. 1999 Apr 5;189(7):1093-100
pubmed: 10190900
BMC Genomics. 2011 Jun 07;12:295
pubmed: 21645414
J Immunol. 2018 Apr 15;200(8):2640-2655
pubmed: 29549179
Hum Immunol. 2008 Jul;69(7):443-64
pubmed: 18638659
Immunogenetics. 2013 Oct;65(10):725-36
pubmed: 23846852
J Immunol. 2004 Jan 1;172(1):356-69
pubmed: 14688344
Tissue Antigens. 2006 Apr;67(4):277-83
pubmed: 16634863
PLoS One. 2010 Dec 29;5(12):e15115
pubmed: 21206914
Genome Res. 2009 May;19(5):757-69
pubmed: 19411600
J Immunol. 2007 Jul 1;179(1):491-504
pubmed: 17579070
Mol Cells. 2010 Sep;30(3):201-7
pubmed: 20803091
J Immunol. 2014 Feb 15;192(4):1907-17
pubmed: 24453246
J Immunol. 2007 Apr 1;178(7):4402-10
pubmed: 17371997
J Immunol. 2009 Mar 15;182(6):3628-37
pubmed: 19265141
PLoS Pathog. 2011 Mar;7(3):e1001316
pubmed: 21423672
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Gene. 2011 Mar 15;474(1-2):39-51
pubmed: 21185924
Immunogenetics. 2014 Nov;66(11):597-611
pubmed: 25139336
Nat Rev Immunol. 2013 Feb;13(2):133-44
pubmed: 23334245
Hum Immunol. 2018 Dec;79(12):825-833
pubmed: 30321631
Eur J Immunol. 2005 Jul;35(7):2191-9
pubmed: 15940669
J Immunol. 2017 Apr 15;198(8):3157-3169
pubmed: 28264973
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Immunogenetics. 2010 May;62(5):295-306
pubmed: 20204612
Genetics. 1981 Jul;98(3):625-40
pubmed: 17249104
Immunogenetics. 2012 Oct;64(10):719-37
pubmed: 22752190
Immunogenetics. 2018 Sep;70(9):571-583
pubmed: 29869002
J Immunol. 2011 Jul 1;187(1):11-9
pubmed: 21690332
Annu Rev Immunol. 2013;31:227-58
pubmed: 23516982

Auteurs

Laura A Leaton (LA)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.
Department of Microbiology & Immunology, University of Colorado, Aurora, CO, United States.

Jonathan Shortt (J)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.

Katherine M Kichula (KM)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.
Department of Microbiology & Immunology, University of Colorado, Aurora, CO, United States.

Sudan Tao (S)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.
Department of Microbiology & Immunology, University of Colorado, Aurora, CO, United States.
Blood Center of Zhejiang Province, Hangzhou, China.

Neda Nemat-Gorgani (N)

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, United States.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.

Alexander J Mentzer (AJ)

Wellcome Trust Centre for Human Genetics, and Jenner Institute, University of Oxford, Oxford, United Kingdom.

Stephen J Oppenheimer (SJ)

Institute of Social and Cultural Anthropology, School of Anthropology and Museum Ethnography, University of Oxford, Oxford, United Kingdom.

Zhihui Deng (Z)

Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen, China.

Jill A Hollenbach (JA)

Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.

Christopher R Gignoux (CR)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.

Lisbeth A Guethlein (LA)

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, United States.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.

Peter Parham (P)

Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, United States.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.

Mary Carrington (M)

Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
Ragon Institute of the Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States.

Paul J Norman (PJ)

Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, CO, United States.
Department of Microbiology & Immunology, University of Colorado, Aurora, CO, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Sciences de l'information › Sources d'information › Services d'information › Documentation › Données de séquences moléculaires › Séquence d'acides aminés › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Eucaryotes › Animaux › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes biologiques › Évolution biologique › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes génétiques › Génotype › Hétérozygote › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Cellules tueuses naturelles › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles moléculaires › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Disciplines des sciences naturelles › Sciences de la Terre › Géographie › Phylogéographie › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Métabolisme › Liaison aux protéines › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Conformation moléculaire › Conformation des protéines › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Conformation moléculaire › Conformation des protéines › Éléments structuraux des protéines › Motifs et domaines d'intéraction protéique › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs de cellules tueuses naturelles › Récepteurs KIR › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes génétiques › Sélection génétique › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Conservation, Extensive Heterozygosity, and...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Conservation, Extensive Heterozygosity, and...